Samraat S. Raha - 09 Mar 2026 Form 4 Insider Report for MYRIAD GENETICS INC (MYGN)

Role: President and CEO, Director
Signature: By: Justin Hunter For: Samraat S. Raha
Issuer symbol: MYGN
Transactions as of: 09 Mar 2026
Net transactions value: +$199,844
Form type: 4
Filing time: 09 Mar 2026, 19:03:13 UTC
Previous filing: 12 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Raha Samraat S.	President and CEO, Director	322 NORTH 2200 WEST, SALT LAKE CITY	By: Justin Hunter For: Samraat S. Raha	09 Mar 2026	0001738340

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MYGN	Common Stock	Purchase	$199,844	+40,000	+8.8%	$5.00	493,104	09 Mar 2026	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.97 to $5.00, inclusive. The reporting person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Content

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.97 to $5.00, inclusive. The reporting person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.